BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7587189)

  • 21. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Menstrual blood loss and body iron stores in Brazilian women.
    Andrade AT; Souza JP; Shaw ST; Belsey EM; Rowe PJ
    Contraception; 1991 Mar; 43(3):241-9. PubMed ID: 2036795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive value of serum ferritin in anemia development after insertion of T Cu 220 intrauterine device.
    Piedras J; Córdova MS; Pérez-Toral MC; Lince E; Garza-Flores J
    Contraception; 1983 Mar; 27(3):289-97. PubMed ID: 6851561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of 1-year use of the CuT 380A and oral contraceptive pills on hemoglobin and ferritin levels.
    Hassan EO; el-Husseini M; el-Nahal N
    Contraception; 1999 Aug; 60(2):101-5. PubMed ID: 10592857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Menstrual blood loss of TCu-380 A and TCu-200 B IUDs.
    El-sheikha Z; Hamza A; Mahmoud M
    Popul Sci; 1990 Jul; ():55-62. PubMed ID: 12343358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ferritin, a faithful reflection of iron deficiency in IUD wearers with mild vaginal spotting.
    Blum M; Ariel J; Zacharowitch D
    Adv Contracept; 1991 Mar; 7(1):39-42. PubMed ID: 1872195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iron-deficiency anemia and long-term use of copper-bearing IUDs.
    Goh TH; Hariharan M
    Contracept Deliv Syst; 1982 Jan; 3(1):17-20. PubMed ID: 12264123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anaemia and menstrual blood loss studies in women using multiload Cu250 and progestasert IUDs.
    Goh TH; Hariharan M; Chan GL
    Contraception; 1984 Apr; 29(4):359-66. PubMed ID: 6744857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A simple and feasible questionnaire to estimate menstrual blood loss: relationship with hematological and gynecological parameters in young women.
    Toxqui L; Pérez-Granados AM; Blanco-Rojo R; Wright I; Vaquero MP
    BMC Womens Health; 2014 May; 14():71. PubMed ID: 24886470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Menstrual blood loss estimates in women using copper 7 and multiload-250 intrauterine devices.
    Pedrón N; Gallegos AJ; Lozano M; Aznar R
    Contraception; 1982 Nov; 26(5):475-85. PubMed ID: 7160180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrauterine device use among women with uterine fibroids: a systematic review.
    Zapata LB; Whiteman MK; Tepper NK; Jamieson DJ; Marchbanks PA; Curtis KM
    Contraception; 2010 Jul; 82(1):41-55. PubMed ID: 20682142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study.
    Tatum HJ; Beltran RS; Ramos R; Van Kets H; Sivin I; Schmidt FH
    Am J Obstet Gynecol; 1996 Nov; 175(5):1231-5. PubMed ID: 8942493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study.
    Luukkainen T; Allonen H; Haukkamaa M; Holma P; Pyörälä T; Terho J; Toivonen J; Batar I; Lampe L; Andersson K
    Contraception; 1987 Aug; 36(2):169-79. PubMed ID: 3123132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Menstrual problems and side effects associated with long-term TCu 380A IUD use in perimenopausal women.
    Reinprayoon D; Taneepanichskul S
    Contraception; 1998 Jun; 57(6):417-9. PubMed ID: 9693403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hematologic characteristics in IUD users.
    Nehra PC; Magyar DM
    Contracept Deliv Syst; 1982 Apr; 3(2):149-54. PubMed ID: 12338169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levonorgestrel intrauterine device in the treatment of menorrhagia in Chinese women: efficacy versus acceptability.
    Tang GW; Lo SS
    Contraception; 1995 Apr; 51(4):231-5. PubMed ID: 7796588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Menstrual blood loss (MBL) in nulliparous Kenyan women.
    Wanjohi JK; Sekadde-kigondu CB; Maina FW; Mati JK
    J Obstet Gynaecol East Cent Africa; 1983 Mar; 2(1):23-6. PubMed ID: 12267056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Menstrual flow duration and spotting following Multiload Copper 250 intra-uterine device insertion.
    Goh TH; Ang ES; Yip YC
    J Obstet Gynaecol (Lahore); 1983 Oct; 4(2):127-8. PubMed ID: 12279948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of copper intrauterine contraceptive devices (Cu-7-IUD) on the menstrual blood-loss.
    Larsson B; Hamberger L; Rybo G
    Acta Obstet Gynecol Scand; 1975; 54(4):315-8. PubMed ID: 1199700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.